drugset / Trial / NCT00231647

A Study on Efficacy and Safety of Topiramate OROS Controlled-Release in Obese, Type 2 Diabetic Subjects Managed With Diet or Metformin

NCT00231647

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the effectiveness and safety of a topiramate controlled-release formulation in the treatment of obese, type 2 diabetic patients managed with diet alone or combined with metformin.

Timeline

Start
2004-02
Primary completion
Completion
2004-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 175 mg Oral